Embryonal kidney cell tumors develop in rats given the alkylating agent N-nitroso-N'-methylurea as neonates. These tumors resemble the childhood Wilms tumors in their histopathology. Deletions and mutations in the Wilms tumor suppressor gene, WTI, are present in up to 6% of childhood nephroblastomas. To investigate the role of WTI in rat kidney tumorigenesis, we studied the genetic alterations in WTI and its target genes. Point mutations were found in WTI cDNA in 7 of 18 kidney tumors. Mesenchymal tumors contained G --A transition mutations in codons 128, 364, and 372, typical of the methylating action of N-nitroso-N'-methylurea on DNA. Each of the four nephroblastomas contained the same T -+ A mutation at codon 111 of WTI, reflective of transversion mutagenesis by N-nitroso-N'-methylurea in vivo. Like Wilms tumors, mRNA levels of WTI, IGF2, Pax-2, and MK genes were higher than newborn kidney in the majority of the tumors. The histopathology of the rat kidney tumors and the genetic alterations are reminiscent of those observed in Wilms tumors, establishing this as a relevant model system for the human disease.
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Wilms tumors (WTs) are neoplasms of the embryonal kidney that occur in 1 in 10,000 young children (1) . In heritable WTs, a region of chromosome 11p13 was found to be commonly deleted. By positional cloning, the tumor suppressor gene WTI was isolated from this region (2) . More detailed examination of WTI in WTs has revealed missense point mutations and small and large deletions (2) (3) (4) . WTI is expressed at high levels in the developing urogenital system (2) (3) (4) . Other regions of WTI expression include the uterus, spinal cord, spleen, abdominal wall musculature, mesothelial lining of organs within the thoracic cavity, and the central nervous system (4) . Intragenic deletions in WTI combined with the finding of high levels of expression of WTI in fetal kidney strongly support a role for this gene in Wilms tumorigenesis. The WTI gene encodes a transcription factor containing four zinc fingers of the Cys2His2 type, in the C terminus, with a Pro-rich N terminus. The WT1 protein functions as a potent repressor and/or activator of transcription in vivo by binding to multiple sites in the promoter sequences of several growthrelated genes such as EGRI (5) , IGF2 (6) , PDGFA chain (7, 8) , and IGFIR (9) . Mutations in the WT1 protein result in loss of DNA binding or transcription repression function (5) (6) (7) (8) (9) , with ensuing inappropriate constitutive expression of the growth factors leading to neoplastic transformation.
An animal model system that fulfills the criteria of both the phenotype and genotype of embryonal kidney tumors will be a valuable tool to decipher the molecular events leading to this childhood disease. To our knowledge, such a model has not been described. Mutant SeyI)eY/+ heterozygote mice were proposed as an animal model for WT (10) . These mice lack the region of the mouse chromosome 2 encompassing the aniridia and WTI genes. They display the small eye defect associated with deletion of the aniridia gene, AN2, but no nephroblastomas were seen (10) . In another study, targeted inactivation of the WTI locus led to death of the homozygous mutant WTI embryos, with a failure to develop kidneys and gonads (11) . Mice heterozygous for the mutant WTI allele, however, undergo normal development and do not develop any malignancies (11) . Obviously, the loss of one allele of WTI in the mouse is insufficient for kidney tumor initiation (11) or the urogenital anomalies typical of patients with WAGR (Wilms tumor, aniridia, genitourinary abnormalities, mental retardation) syndrome (2, 4) .
In this study, we tested the validity of the N-nitroso-N'-methylurea (NMU)-induced rat kidney tumors of embryonal cell origin as an animal model system for childhood WTs. The results reported here show that the rat tumors resemble their human counterpart in their biology and genetic events such as mutations in WTI and aberrant expression of mitogenic growth factor genes.
MATERIALS AND METHODS
Tumor Induction. Newborn Sprague-Dawley rats of both sexes were administered a single subcutaneous injection (0.05 ml) of NMU (50 mg/kg of body weight) dissolved in normal saline acidified with acetic acid (0.05%) between days 2 and 4 after birth. Animals were sacrificed between 4 and 8 months after NMU injection, when the abdominal tumor became palpable or if continuous weight loss was observed.
Isolation of DNA and RNA. Total cellular nucleic acids (RNA and DNA) and proteins were extracted simultaneously from the tumor tissues as described (12) .
Cloning and Sequencing of WTI cDNA. Three overlapping fragments of WTI cDNA (13, 14) PCR-amplified from 18 NMU-induced kidney tumors and 10 normal kidneys from Sprague-Dawley rats, individually, were (i) a 364-bp fragment (BO/B1, nt -66 to 298) representing 5 The age of the rat at the time of carcinogen exposure appears to dictate the incidence and histological type of the kidney tumors. In contrast to newborn rats, late-stage fetuses (days [17] [18] [19] [20] [21] of gestation) exposed to the carcinogen through the transplacental route have a low (7-10%) kidney tumor incidence that is predominantly of the mesenchymal type (15) (16) (17) , while adult rats given NMU develop carcinomas of the kidney (20%o) derived from the proximal or distal tubular epithelial cells (unpublished observations).
Histopathology of the Kidney Tumors. The rat kidney tumors are oftwo main types, mesenchymal and nephroblastomas (15) (Fig. 1) . Mesenchymal tumors consist of highly invasive sarcomatous cells, growing densely and often invading the renal parenchyma. Abortive tubules and glomeruli are rare (Fig. 1A) . Thirty percent of the NMU-induced tumors were classified as embryonal nephromas or nephroblastomas. The pale-colored tumors appear distinctly separated from the surrounding kidney tissue by a stromal cap-
sule. These tumors are composed, primarily, of small stellate cells that form tight nests or sheets, with features typical of immature blastema. The blastemal cells coexist with immature spindle cell stroma and partially differentiated embryonic tubules and glomeruloid bodies (Fig. 1B) . Typically, WTs are histologically diverse, and this feature was manifest in the rat tumors as well. The third mixed-cell type of tumor (Fig. 1C) , 6% of the total, consisted of thick strands of spindle-shaped cells with hyperchromatic nuclei and interlacing mature tubules (15) . As in human WTs (1), triphasic, biphasic, and monophasic histology is observed in the nephroblastomas, with variations in the relative proportions ofthe epithelial, mesenchymal, and stromal components and in the level of cellular differentiation. Thus, the histopathological features of the NMU-induced rat kidney tumors strongly reflect those typically observed in human WTs.
Point Mutations in the WTI cDNA of Neonatally Induced Kidney Tumors. The WT1 protein appears to play a major role in the switch between proliferative and differentiation pathways in the urogenital system (18) (19) (20) (21) . Supportive evidence is provided by (i) the presence of somatic mutations in the WTI locus in WTs (2-4); (ii) germ-line mutations in WTI in patients with Denys-Drash syndrome (20, 21) , characterized by abnormal genital development; and (iii) the absence of kidneys in mice lacking a functional WTI gene (11) . Based on these observations, we reasoned that the coding sequences of the WTI gene might be altered in the NMUinduced rat kidney tumors of embryonal cell origin.
The entire WTI cDNA (nt -66 to 1347) from 18 kidney tumors was cloned and sequenced. At least 10 clones from two reverse-transcribed PCR products were sequenced to determine mutation frequency, to assess loss of alleles, and to discount PCR artifacts. Polymorphisms were ruled out by sequencing reverse-transcribed WT1 PCR products of 10 normal Sprague-Dawley rat kidneys.
Nucleotide sequencing of the WTI cDNA revealed the . WT1. In another kidney tumor (1382), a missense mutation was detected in the same region of WT1 in codon 128; a C383 --T mutation that would lead to a Pro --Leu replacement in the mutated WT1. In a mesenchymal kidney tumor (1166), a C1091 T point mutation was detected in the second zinc-finger region. As a result, a highly conserved phosphorylation site (Tony Hunter, personal communication), Ser364 (TCT) would be replaced by a Phe (TTT) in the mutated WT1. A second mutation in this region was discovered in another mesenchymal tumor (1975), a C'114 -* T transition that would lead to the replacement of a highly conserved zinc binding His372 in the second zinc finger with Tyr ( Fig. 2A) . Table 2 summarizes the spectrum of mutations seen in WT1 in the kidney tumors induced by NMU. Along with the mutated WTI allele, tumors 1382 and 1166 retained the wild-type WTI allele. The continued presence of the wild-type allele in these tumors suggests that the mutant WT1 protein, like the tumor suppressor protein p53, has the ability to act as a dominant oncogenic product or in a dominant negative fashion by sequestering the wild-type protein (22, 23) .
Aberrant Expression of WT1, IGF2, MK, and Pax-2 mRNA in NMU-Induced Kidney Tumors. Understanding the multigenic etiology proposed for the pathogenesis of WTs requires investigation into the contribution not only of WTI but also of other genes that show altered expression specifically in the tumor tissue (24) . Overabundance of mRNA expression and, hence, inappropriate activity of WTI, IGF2, MK, and Pax-2 genes has been implicated in the etiology of WTs (24) (25) (26) (27) (28) (29) . Insulin-like growth factor II (IGF2) and midkine (MK) are fetal mitogens that are expressed only in the early stages of development of the kidney in humans and may have autocrine effects in WT progression. Pax-2, a murine paired-boxcontaining gene, is active during embryonic development but repressed upon terminal differentiation of the renal tubule epithelium. These genes show high-level mRNA expression during kidney development but are down-regulated to low or undetectable levels in the adult (19, (24) (25) (26) (27) (28) (29) . We determined whether rat kidney tumors induced by NMU show anomalous expression patterns of these genes.
In the panel of 18 NMU-induced tumors, 7 displayed levels of IGF2 mRNA 2-to 7.5-fold higher than newborn kidney, 4 had levels comparable to newborn kidney (Table 2) , while the remaining 7 had no detectable IGF2 expression. Compared to newborn kidney, 4 kidney tumors show parallel increases in MK and WT1 mRNA levels. All four nephroblastomas with codon 111 mutation showed high IGF2, WT1, and MK mRNA expression (tumors 1972, 1638, 1268, and 1771; Table  2 and Fig. 3 ), raising the possibility that WT1 normally represses its own transcription and that of IGF2 (6) and MK. In mesenchymal kidney tumors, no clear pattern of mRNA expression emerges, except that IGF2 is present at detectable levels in 7 of 14 tumors. Pax-2 mRNA levels varied widely in the tumors. In contrast to the mouse kidney, where WT1 and Pax-2 expression is down-regulated in the adult (24, 29) , Pax-2 mRNA levels in rat kidney remain unchanged, while WT1 mRNA is present at lower but easily detectable levels throughout life (Fig. 3) . Eight of the 18 rat kidney tumors showed low or undetectable levels of Pax-2 expression, while the remainder showed levels comparable to newborn or adult kidney ( Fig. 3 and Table 2 ), their levels presumably varying with the extent of tubular epithelial differentiation in the tumor. These results are consistent with a function for Pax-2 as an epithelial cell differentiation gene, such that a lack of expression results in the dedifferentiated state of the tumor tissue. In essence, genes that are known to be overexpressed in human WTs show abnormal expression patterns in the carcinogen-induced rat kidney neoplasms.
DISCUSSION
The classical correlation between malignancy and aberrant development is well illustrated by WTs. The tumors arise from primitive metanephric blastemal cells that would normally differentiate into components of the nephron. In the rat, highest WT1 mRNA expression coincides with terminal differentiation of kidney structures in the first week after birth (14) , while in the human fetus, the same stage is achieved by week 36 of gestation (18, 19) . The WT1 mRNA expression pattern, therefore, mirrors the delayed terminal differentiation of kidney structures that occurs in the rat as a neonate. In all likelihood, the continued postnatal terminal differentiation of the kidney, which presents suitable target cells, accounts for the high incidence (80%) of embryonal (2) (3) (4) 23) . A C383-G -+ TA mutation was present in codon 128 in a mesenchymal tumor. The two mutations, in codon 111 and codon 128, lie in the region ofWT1 protein that has been identified as the regulatory domain (aa 84-179) that is required for transcriptional suppression of the PDGFA chain promoter (7, 8) .
In the mesenchymal kidney tumor (1166), as a result of the C109-+ T point mutation in the second zinc-finger region, the highly conserved phosphorylation site at Ser3" (TCT) would be replaced by Phe (TTT) in the mutated gene product ( Fig. 2A and Table 2 ). Ser364 also precedes the first contact Arg of the second zinc finger (32) . This mutation is identical to the one discovered in the WTI gene from a human leukemia cell line, CEM (2) (3) (4) (35) (36) (37) . The premutagenic lesion 02-dT, a DNA adduct formed by N-ethyl-N'-nitrosourea, a compound closely related to NMU, is among the least efficiently repaired and, therefore, the most persistent in mammalian cells (36, 37) . Incorporation of dA and dT occurs opposite the premutagenic lesion. Whereas incorporation of dA impedes DNA synthesis, incorporation of dT is efficiently extended, leading to ART --TEA transversion (35) (36) (37) . In the remaining three tumors, the C --T transitions concur with the well-known mutagenic activity of NMU, the formation of 06-methylguanine adducts (35) (36) (37) in the nontranscribed strand of DNA. The precise nature of the mutations in WTI in the kidney tumors suggests that, similar to RAS, they could occur by direct interaction of NMU with the WTI gene (38) (39) (40) . It is conceivable that codon 111 mutations in the more differentiated nephroblasts give rise to nephrogenic nephroblastomas, while random WTI mutations in the primitive metanephric mesenchymal cells give rise to the more aggressive stromagenic nephromas.
In summary, the histopathology ofthese embryonal kidney tumors, the occurrence of mutations in WTI, and altered expression of WT1, IGF2, MK, and Pax-2 mRNAs support the NMU-induced rat kidney tumors as a valid and valuable model for WTs in human. The clear advantage of an animal model is the ease and reproducibility of frequent tumor induction using a direct-acting chemical carcinogen. In the rat, after the administration ofNMU, the temporal alterations at the genetic and biological level can be followed through the stages of initiation, promotion, and progression. In children, WTs occur more frequently in kidneys that contain persistent renal stem cells, a condition known as nephroblastomatosis or nephrogenic rests, which may represent the prelitnant stage of the disease (41) . Recently, these rests have been shown to contain WTI mutations, supporting a role for WTI in the early stages of tumorigenesis (41) . Others argue that such rests occur in infant autopsies far too frequently to be a premalignant stage of WTs (42) . The ability to culture the urogenital sinus from the carcinogen-treated rat fetus that differentiates into components of the urogenital system (43, 44) offers a powerful potential tool to resolve the controversy and to observe their stepwise progression in organ culture.
